The big wins are
RLYP $16 to $32
TBRA $5 to $38
AUPH $2.25 to $8
I am here again to find undervalued biotech stocks that will double or quadruple from here.
I found that multi bagger stocks have 3 criteria and they are
1. It has to be small cap stocks preferably under $500 million or less but can go up to $1 billion
2. The company's drug has to address a big market such as cancer and other diseases that has a big large market.
3. The drug has to prove after phase 2 that it is both effective and safe.
I think the next big winners will be VSAR, GBT, DEPO and FOLD.
I will be posting more picks as soon as I find a new gem.